Galectin Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 2.13 M | $5.87 M | 0.86% | 3.43% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.61 M | $4.42 M | 100.00% | 2.58% |
AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 1.21 M | $3.33 M | 100.00% | 1.95% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1.18 M | $3.25 M | 4.98% | 1.90% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 862,542 | $2.37 M | 2.47% | 1.39% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 500,000 | $1.38 M | 100.00% | 0.80% |
COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 483,264 | $1.33 M | -0.02% | 0.78% |
WEALTHSPIRE ADVISORS, LLC | 11/13/2024 | 398,374 | $1.10 M | 0.00% | 0.64% |
GENEOS WEALTH MANAGEMENT INC. | 11/14/2024 | 352,935 | $970,571 | -10.36% | 0.57% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 291,700 | $802,175 | -69.87% | 0.47% |
STATE STREET CORP | 11/14/2024 | 251,014 | $690,289 | 9.32% | 0.40% |
MORGAN STANLEY | 11/14/2024 | 246,080 | $676,721 | 8.30% | 0.40% |
NORTHERN TRUST CORP | 11/13/2024 | 234,280 | $644,270 | 84.51% | 0.38% |
ATRIA WEALTH SOLUTIONS, INC. | 11/08/2024 | 207,100 | $569,525 | -3.13% | 0.33% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 155,000 | $426,250 | 100.00% | 0.25% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 146,200 | $402,050 | 100.00% | 0.23% |
SOLTIS INVESTMENT ADVISORS LLC | 01/03/2025 | 140,750 | $387,063 | 100.00% | 0.23% |
CUTTER & CO BROKERAGE, INC. | 10/25/2024 | 115,488 | $317,592 | 0.00% | 0.19% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 114,720 | $315,000 | 2.31% | 0.18% |
LPL FINANCIAL LLC | 11/08/2024 | 81,908 | $225,247 | -6.13% | 0.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 81,467 | $224,034 | -59.74% | 0.13% |
11/25/2024 | 79,113 | $219,934 | -21.40% | 0.13% | |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 65,073 | $178,951 | 0.00% | 0.10% |
RETIREMENT GUYS FORMULA LLC | 10/21/2024 | 63,817 | $175,497 | 55.06% | 0.10% |
CITADEL ADVISORS LLC | 11/14/2024 | 62,500 | $171,875 | 359.56% | 0.10% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 55,300 | $152,075 | 100.00% | 0.09% |
MARSHALL WACE, LLP | 11/14/2024 | 52,259 | $143,712 | 177.60% | 0.08% |
CITADEL ADVISORS LLC | 11/14/2024 | 51,600 | $141,900 | 1,811.11% | 0.08% |
HORIZON KINETICS ASSET MANAGEMENT LLC | 11/13/2024 | 51,484 | $141,581 | -4.20% | 0.08% |
SYNOVUS FINANCIAL CORP | 11/25/2024 | 48,000 | $132,000 | 0.00% | 0.08% |
TRAYNOR CAPITAL MANAGEMENT, INC. | 10/25/2024 | 42,871 | $117,896 | 0.00% | 0.07% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 42,721 | $117,483 | -33.69% | 0.07% |
KOVITZ INVESTMENT GROUP PARTNERS, LLC | 11/15/2024 | 42,540 | $116,985 | 100.00% | 0.07% |
STRATOS WEALTH PARTNERS, LTD. | 10/17/2024 | 40,450 | $111,238 | 0.00% | 0.07% |
BLAIR WILLIAM & CO/IL | 11/12/2024 | 37,884 | $104,181 | 0.00% | 0.06% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 36,372 | $100,023 | -31.78% | 0.06% |
SOLUTIONS 4 WEALTH, LTD | 11/14/2024 | 36,003 | $99,008 | -0.23% | 0.06% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 35,098 | $96,520 | 0.54% | 0.06% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 33,032 | $90,838 | 46.40% | 0.05% |
D.A. DAVIDSON & CO. | 11/13/2024 | 30,771 | $84,620 | -36.91% | 0.05% |
JPMORGAN CHASE & CO | 12/26/2024 | 30,628 | $84,227 | 161.31% | 0.05% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 29,552 | $81,000 | 100.00% | 0.05% |
BARCLAYS PLC | 11/19/2024 | 28,587 | $79,000 | 309.03% | 0.05% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 27,623 | $75,963 | 0.00% | 0.04% |
SQUAREPOINT OPS LLC | 11/14/2024 | 27,435 | $75,446 | -67.37% | 0.04% |
MARINER, LLC | 11/13/2024 | 26,585 | $73,109 | 0.41% | 0.04% |
VIVALDI CAPITAL MANAGEMENT LP | 11/14/2024 | 24,032 | $66,088 | 0.00% | 0.04% |
BEACON CAPITAL MANAGEMENT, LLC | 11/07/2024 | 23,905 | $65,739 | 0.00% | 0.04% |
GLADSTONE INSTITUTIONAL ADVISORY LLC | 10/28/2024 | 21,750 | $59,813 | 100.00% | 0.03% |
SUMMIT TRAIL ADVISORS, LLC | 11/12/2024 | 20,000 | $55,000 | 0.00% | 0.03% |
Galectin Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 106 institutional investors and hedge funds held shares of Galectin Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 1.65 M
ADVISOR GROUP HOLDINGS, INC.: 1.18 M
Wealthspire Advisors, LLC: 398,374
Geneos Wealth Management Inc.: 388,935
Atria Wealth Solutions, Inc.: 207,100
RETIREMENT GUYS FORMULA LLC: 155,343
15.65% of Galectin Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.01 M shares in the last 24 months. This purchase volume represents approximately $17.05 M in transactions.